Coleman E. Johnson

1.2k total citations · 1 hit paper
3 papers, 925 citations indexed

About

Coleman E. Johnson is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Coleman E. Johnson has authored 3 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 1 paper in Oncology and 1 paper in Genetics. Recurrent topics in Coleman E. Johnson's work include Virus-based gene therapy research (1 paper), CRISPR and Genetic Engineering (1 paper) and Genomics, phytochemicals, and oxidative stress (1 paper). Coleman E. Johnson is often cited by papers focused on Virus-based gene therapy research (1 paper), CRISPR and Genetic Engineering (1 paper) and Genomics, phytochemicals, and oxidative stress (1 paper). Coleman E. Johnson collaborates with scholars based in United States and Hungary. Coleman E. Johnson's co-authors include Corey J. Williams, Kristian M. Hargadon and Balázs Győrffy and has published in prestigious journals such as International Immunopharmacology, Methods in molecular biology and Cancer Genomics & Proteomics.

In The Last Decade

Coleman E. Johnson

3 papers receiving 918 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors

2018 911 citations Kristian M. Hargadon, Coleman E. Johnson et al. International Immunopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Coleman E. Johnson United States	2	663	437	224	147	89	3	925
Corey J. Williams United States	3	664 1.0×	437 1.0×	228 1.0×	148 1.0×	89 1.0×	4	930
Aixa Soyano United States	9	713 1.1×	482 1.1×	234 1.0×	229 1.6×	86 1.0×	30	1.1k
Nana-Ama A.S. Anang United States	4	973 1.5×	762 1.7×	223 1.0×	162 1.1×	68 0.8×	6	1.2k
Kimberley M. Heinhuis Netherlands	10	508 0.8×	261 0.6×	202 0.9×	197 1.3×	66 0.7×	15	797
Raju Vaddepally United States	5	745 1.1×	352 0.8×	202 0.9×	246 1.7×	57 0.6×	10	997
Margaret E. Gatti‐Mays United States	16	746 1.1×	539 1.2×	306 1.4×	170 1.2×	53 0.6×	74	1.1k
Pushpamali De Silva Belgium	21	708 1.1×	478 1.1×	211 0.9×	286 1.9×	140 1.6×	36	1.1k
W.E. Gillanders United States	5	826 1.2×	493 1.1×	231 1.0×	145 1.0×	57 0.6×	6	1.0k
Tae Kon Kim United States	15	417 0.6×	470 1.1×	311 1.4×	99 0.7×	93 1.0×	46	1.0k

Countries citing papers authored by Coleman E. Johnson

Since Specialization

Citations

This map shows the geographic impact of Coleman E. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Coleman E. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Coleman E. Johnson more than expected).

Fields of papers citing papers by Coleman E. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Coleman E. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Coleman E. Johnson. The network helps show where Coleman E. Johnson may publish in the future.

Co-authorship network of co-authors of Coleman E. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Coleman E. Johnson. A scholar is included among the top collaborators of Coleman E. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Coleman E. Johnson. Coleman E. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Hargadon, Kristian M., et al.. (2021). Generation of Functional Gene Knockout Melanoma Cell Lines by CRISPR-Cas9 Gene Editing. Methods in molecular biology. 2265. 25–46. 1 indexed citations

2.

Hargadon, Kristian M., et al.. (2019). The FOXC2 Transcription Factor Promotes Melanoma Outgrowth and Regulates Expression of Genes Associated With Drug Resistance and Interferon Responsiveness. Cancer Genomics & Proteomics. 16(6). 491–503. 13 indexed citations

3.

Hargadon, Kristian M., Coleman E. Johnson, & Corey J. Williams. (2018). Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors. International Immunopharmacology. 62. 29–39. 911 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact